Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-02-06

Clinical Trial Update: Zynrelef Versus Adductor Canal Block [Phase 4]

View source ↗

Summary

This Phase 4 trial at the University of Miami compares Zynrelef with an adductor canal block for knee osteoarthritis and is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZYNRELEF (BUPIVACAINE AND MELOXICAM)

Snippet

Sponsor: University of Miami | Conditions: Knee Osteoarthritis, Arthritis Knee | Phase 4 | Status: NOT_YET_RECRUITING